Diagnosis of Obesity: 2022 Update of Clinical Practice Guidelines for Obesity by the Korean Society for the Study of Obesity - PubMed (original) (raw)

Review

Diagnosis of Obesity: 2022 Update of Clinical Practice Guidelines for Obesity by the Korean Society for the Study of Obesity

Ji-Hee Haam et al. J Obes Metab Syndr. 2023.

Abstract

The prevalence of obesity has consistently increased worldwide, and many obesity-related diseases are emerging as major health problems. Body mass index (BMI) is used to define obesity and is highly correlated with body fat mass. Moreover, obesity-related morbidities increase linearly with the increase in BMI. The Korean Society for the Study of Obesity defined overweight as a BMI ≥23 kg/m2 and obesity as a BMI ≥25 kg/m2, based on a significant increase in obesity-related diseases. A waist circumference of ≥90 cm in men and ≥85 cm in women are defined as abdominal obesity, which is also correlated with obesity-related diseases. These diagnostic criteria are the same as in the previous version; however, the updated guidelines put greater emphasis on the use of morbidity as the basis for obesity and abdominal obesity diagnoses. These new guidelines will help to identify and manage high-risk groups for obesity-related comorbidities among Korean adults.

Keywords: Abdominal obesity; Body mass index; Comorbidity; Diagnosis; Obesity; Waist circumference.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST

The authors declare no conflict of interest.

Figures

Figure 1

Figure 1

The incidence rate of type 2 diabetes, hypertension, and dyslipidemia according to body mass index (BMI) level. Data derived from the National Health Insurance Service Health Checkup Data 2006 to 2015. Adapted from Seo et al.

References

    1. Yang YS, Han BD, Han K, Jung JH, Son JW Taskforce Team of the Obesity Fact Sheet of the Korean Society for the Study of Obesity, author. Obesity fact sheet in Korea, 2021: trends in obesity prevalence and obesity-related comorbidity incidence stratified by age from 2009 to 2019. J Obes Metab Syndr. 2022;31:169–77. doi: 10.7570/jomes22024. - DOI - PMC - PubMed
    1. Seo MH, Kim YH, Han K, Jung JH, Park YG, Lee SS, et al. Prevalence of obesity and incidence of obesity-related comorbidities in Koreans based on National Health Insurance Service Health Checkup Data 2006-2015. J Obes Metab Syndr. 2018;27:46–52. doi: 10.7570/jomes.2018.27.1.46. - DOI - PMC - PubMed
    1. Kim KK, Haam JH, Kim BT, Kim EM, Park JH, Rhee SY, et al. Evaluation and treatment of obesity and its comorbidities: 2022 update of clinical practice guidelines for obesity by the Korean Society for the Study of Obesity. J Obes Metab Syndr. 2023;32:1–24. doi: 10.7570/jomes23016. - DOI - PMC - PubMed
    1. Gray DS, Fujioka K. Use of relative weight and body mass index for the determination of adiposity. J Clin Epidemiol. 1991;44:545–50. doi: 10.1016/0895-4356(91)90218-X. - DOI - PubMed
    1. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9:88. doi: 10.1186/1471-2458-9-88. - DOI - PMC - PubMed

Publication types

LinkOut - more resources